Lv51
1164 积分 2022-10-31 加入
Protection against Amyloid-β Aggregation and Ferroptosis/Oxytosis Toxicity by Arylpyrazolones: Alzheimer’s Disease Therapeutics
26天前
已完结
Applications of Palladium-Catalyzed C–N Cross-Coupling Reactions
2个月前
已完结
Dual JAK and ROCK inhibition with CPL'116 in patients with rheumatoid arthritis with inadequate response to methotrexate: a randomised, double-blind, placebo-controlled, phase 2 trial
3个月前
已完结
Toward immune tolerance in rheumatoid arthritis: Emerging immunotherapies and targets for long-term remission
3个月前
已完结
Toll‐Like Receptor 8 is a Therapeutic Target in Rheumatoid Arthritis
3个月前
已完结
Advances and challenges in Toll-like receptor-targeted therapy for rheumatoid arthritis
3个月前
已完结
Irreversible covalent Bruton's tyrosine kinase inhibitor, TAS5315 versus placebo in rheumatoid arthritis patients with inadequate response to methotrexate: a randomised, double-blind, phase IIa trial
3个月前
已完结
CIGB-814, an altered peptide ligand derived from human heat-shock protein 60, decreases anti-cyclic citrullinated peptides antibodies in patients with rheumatoid arthritis
3个月前
已完结
OP0079 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-AND-TOCILIZUMAB CONTROLLED PHASE II TRIAL OF VDJ-001, A HIGH-AFFINITY IL-6R ANTAGONIST ANTIBODY, FOR THE TREATMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS
3个月前
已关闭
IRF5 Acts as a Potential Therapeutic Marker in Inflammatory Bowel Diseases
4个月前
已完结
皖公网安备34019202002308
